EQT has restarted the sale of Ginko's mainland China business after a previous deal collapsed. The private equity firm is now targeting a valuation of at least $1 billion for the contact lens maker's largest market. This renewed effort follows a failed transaction with Advent International, which walked away by paying a breakup fee.

Goldman Sachs and JPMorgan are managing the process, targeting both financial sponsors and strategic buyers. Ginko operates a diverse portfolio in China, producing disposable and conventional contact lenses alongside specialized lens care solutions. These operations form the core of the company's footprint in the region, making the asset a high-value target for newcomers.

This divestment represents a second attempt to exit an investment originally secured in 2022 by Baring Private Equity Asia. That entity merged with EQT later that same year, leaving the current firm to manage the exit. EQT is now leveraging two top-tier investment banks to finalize the divestiture of Ginko China.